International Vaccine Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:International Vaccine Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9332
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International Vaccine Institute (IVI) is a non-profit organization that discovers, develops and delivers vaccines. The organization’s vaccines include bivalent inactivated oral cholera vaccine, Vi-DT typhoid conjugate vaccine, bivalent typhoid conjugate vaccine, shigella vaccine, norovirus vaccine, rotavirus vaccine, Vi-PspA conjugate vaccine. It develops vaccines for disease such as cholera, enteric fever, typhoid and dengue, and others. IVI conducts research on hepatitis E and provides support to partners in vaccine development for other diarrheal diseases including rotavirus, shigellosis, enterotoxigenic E. coli, norovirus, tuberculosis, and pneumococcal disease. IVI offers vaccine discovery and design, vaccine development and research services. The organization’s research services include collection of epidemiologic, economic and socio behavioral data, studies of vaccines feasibility and data synthesis and dissemination. IVI is headquartered in Seoul, South Korea.

International Vaccine Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Vaccine Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International Vaccine Institute, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Indian Council of Medical Research to Enter into Agreement with International Vaccine Institute 10
MilliporeSigma Enters into Research Agreement with International Vaccine Institute 11
Incepta Vaccine Enters into Agreement with International Vaccine Institute 12
Intravacc Partners with International Vaccine Institute 13
SK Chemicals and International Vaccine Institute Enters into Agreement 14
Asset Transactions 15
PT Bio Farma Acquires Vaccine Technology from International Vaccine Institute 15
International Vaccine Institute – Key Competitors 16
International Vaccine Institute – Key Employees 17
International Vaccine Institute – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
International Vaccine Institute, Pharmaceuticals & Healthcare, Key Facts, 2016 2
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Vaccine Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Vaccine Institute, Deals By Therapy Area, 2012 to YTD 2018 8
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Indian Council of Medical Research to Enter into Agreement with International Vaccine Institute 10
MilliporeSigma Enters into Research Agreement with International Vaccine Institute 11
Incepta Vaccine Enters into Agreement with International Vaccine Institute 12
Intravacc Partners with International Vaccine Institute 13
SK Chemicals and International Vaccine Institute Enters into Agreement 14
PT Bio Farma Acquires Vaccine Technology from International Vaccine Institute 15
International Vaccine Institute, Key Competitors 16
International Vaccine Institute, Key Employees 17

List of Figures
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[International Vaccine Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dassault Systemes SE (DSY):企業の財務・戦略的SWOT分析
    Dassault Systemes SE (DSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • The Weir Group Plc (WEIR):石油・ガス:M&Aディール及び事業提携情報
    Summary The Weir Group Plc (Weir Group) is a provider of engineering solutions. The company designs and manufactures highly engineered products and services for minerals, oil and gas, and power industries. Its products and service portfolio include pressure pumping equipment, pressure control produc …
  • Golden Gate Capital:企業の戦略的SWOT分析
    Golden Gate Capital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Atriva Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Atriva Therapeutics GmbH (Atriva Therapeutics) is a developer of antiviral therapies that develops therapies against seasonal and pandemic influenza. The company develops ATR-001 drug candidate, a MEK inhibitor which targets influenza. It also offers repurposing existing MEK inhibitors, orig …
  • The J.M. Smucker Co:企業の戦略・SWOT・財務分析
    The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report Summary The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Eris Lifesciences Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Eris Lifesciences Ltd (Eris Lifesciences) is a pharmaceutical company that manufactures and commercializes generics products. The company through its divisions provides wide range of products including Maxum, Decal, Eritel H, Eritel CH 80 LS, Glimisave Max Forte 1, Mac Rabonik Plus, Vomisave …
  • Innocoll AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Innocoll AG (Innocoll), formerly Innocoll Holdings Plc is a pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product Xaracoll, a bupivacaine HC …
  • Blackline Safety Corp. (BLN):企業の財務・戦略的SWOT分析
    Blackline Safety Corp. (BLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • JFE Holdings, Inc.:企業の戦略・SWOT・財務情報
    JFE Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JFE Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bouwinvest Real Estate Investment Management B.V.:企業の戦略・SWOT・財務情報
    Bouwinvest Real Estate Investment Management B.V. - Strategy, SWOT and Corporate Finance Report Summary Bouwinvest Real Estate Investment Management B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Boustead Heavy Industries Corp Bhd:企業の戦略・SWOT・財務情報
    Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report Summary Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Huneed Technologies:企業の戦略・SWOT・財務分析
    Huneed Technologies - Strategy, SWOT and Corporate Finance Report Summary Huneed Technologies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Samsung Electronics Co Ltd (005930):医療機器:M&Aディール及び事業提携情報
    Summary Samsung Electronics Co Ltd (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, printer, …
  • Bosch Sensortec GmbH:企業の戦略的SWOT分析
    Bosch Sensortec GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Abdullah Al-Othaim Markets Co.
    Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report Summary Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Repro-Med Systems Inc (REPR):企業の財務・戦略的SWOT分析
    Summary Repro-Med Systems Inc (RMS) is a medical device company that develops and manufactures home and specialty infusion solutions. The company's products include syringe infusion system, subcutaneous safety needle sets, precision flow rate tubing, and hand held medical suction products. It offers …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Lansdowne Oil & Gas plc (LOGP):企業の財務・戦略的SWOT分析
    Summary Lansdowne Oil & Gas Plc (Lansdowne Oil & Gas) is an independent oil and gas exploration and production company. The company acquires, explores and develops crude oil and natural gas appraisals in the North Celtic Sea Basin offshore in southern Ireland. It develops Barryroe Field in the North …
  • Pon Holdings BV:企業の戦略・SWOT・財務情報
    Pon Holdings BV - Strategy, SWOT and Corporate Finance Report Summary Pon Holdings BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • MicroPort Scientific Corp (853):企業の財務・戦略的SWOT分析
    Summary MicroPort Scientific Corp (MicroPort) operates as a medical device company that develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, electronic laparoscope devices, neurova …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆